Richard J. Rodgers - Oct 29, 2022 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Director
Signature
/s/ John A. Herrmann III, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Oct 29, 2022
Transactions value $
$0
Form type
4
Date filed
11/1/2022, 05:10 PM
Previous filing
Oct 4, 2022
Next filing
Jan 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Stock Option (Right to buy) Award $0 +17.1K $0.00 17.1K Oct 29, 2022 Common Stock 17.1K $23.02 Direct F1
transaction NVAX Restricted Stock Units Award $0 +11.4K $0.00 11.4K Oct 29, 2022 Common Stock 11.4K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the October 29, 2022 grant date (the "Grant Date"), in each case subject to continued service on the Company's Board of Directors through such vesting date.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F3 The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.